Although all naïve mice developed tumors that grew progressively, each of the mice treated with etoposide in combination with anti-mCTLA-4 mAb (n = 4) rejected tumor rechallenge, leading the authors to interpret that combination of CTLA-4 blockade plus etoposide generated a memory immune response (Table 1). Here, CTLA4 is linked to neoplasm.